Stemtech Corporation and Viago Announce Strategic Merger
NAPLES, FL / ACCESSWIRE / November 20, 2024 / Stemtech Corporation (OTCQB:STEK) and Seacret Direct, LLC (doing business as VIÁGO)...
Staff
ALL Study Groups using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria’s 12-Week GLP-1, Diabetes Animal Study
DehydraTECH-liraglutide and a select DehydraTECH-CBD formulation were the top performing groups in the Study outperforming the Rybelsus® control group in...
Overcharged, Overdiagnosed, and Overwhelmed? Quizzify Teaches Patients to Take Control of Healthcare Spending
ful. Health and Quizzify give patients the tools to ask smarter questions, make better choices, and save money.DUBUQUE, IA /...
Safe Supply Streaming Co Ltd. Announces Closing of Acquisition of Drug Lab 118 Ltd
Toronto, Ontario--(Newsfile Corp. - November 20, 2024) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe...
Safe Supply Streaming Co Ltd. Announces Closing of Acquisition of Drug Lab 118 Ltd
Toronto, Ontario--(Newsfile Corp. - November 20, 2024) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe...
Unite Us Advances Its Data-Driven Social Needs System to Elevate Community Care and Drive Measurable Impact
The proprietary, innovative framework delivers unmatched accuracy and actionable insights to meet evolving social needs and empower targeted interventionsNew York,...
Unite Us Advances Its Data-Driven Social Needs System to Elevate Community Care and Drive Measurable Impact
The proprietary, innovative framework delivers unmatched accuracy and actionable insights to meet evolving social needs and empower targeted interventionsNew York,...
First Patient Dosed in Aptevo’s Ongoing RAINIER Trial Achieves 90% Reduction in Leukemic Blasts Within the First 30 Days of Treatment, Continues Overall Efficacy Trend Seen in Prior Mipletamig AML Studies
Potential to redefine frontline AML treatment being evaluated in clinic: Mipletamig, CD3 x CD123 bispecific, in combination with standard of...
First Patient Dosed in Aptevo’s Ongoing RAINIER Trial Achieves 90% Reduction in Leukemic Blasts Within the First 30 Days of Treatment, Continues Overall Efficacy Trend Seen in Prior Mipletamig AML Studies
Potential to redefine frontline AML treatment being evaluated in clinic: Mipletamig, CD3 x CD123 bispecific, in combination with standard of...
Aesthetic Surgical Images Has Been Recognized in the Best of Omaha Awards
Award-winning cosmetic surgery practice recognized for breast augmentation, tummy tuck, and body contouring excellenceOMAHA, NE / ACCESSWIRE / November 20,...
Aesthetic Surgical Images Has Been Recognized in the Best of Omaha Awards
Award-winning cosmetic surgery practice recognized for breast augmentation, tummy tuck, and body contouring excellenceOMAHA, NE / ACCESSWIRE / November 20,...
Leafbuyer Technologies, Inc. Announces Record Results: 38% Increase in Quarterly Revenue and 53% Increase in Gross Margins
Financial Highlights:Revenue rose 38% from $1,169,622 to $1,609,473 in the second quarter of fiscal year 2024Revenue Increase was more than...
MIRA Reveals Innovative Phase I/IIa Protocol Design and Selection of Clinical Trial Site
Backed by a Strong Balance Sheet, MIRA Accelerates Toward Becoming a Clinical-Stage Company and Advancing Breakthroughs in Pain and Depression...
UniDoc Showcases H3 Health Cube in Italy
AI-equipped H3 Health Cube Displayed at the Annual Assembly of the National Association of Italian Municipalities VANCOUVER, BC / ACCESSWIRE...
Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx’s Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
The Northwell Health Cancer Institute is the Most Recent Clinical Site to Join the TIGeR-PaC Study, and RenovoRx Aims to...
StoryCatch Partners Acquires EmpiraMed
Combined organization will unlock patterns in complex participant populations, driving physical and mental health improvementWELLESLEY HILLS, Mass., Nov. 20, 2024...
Silexion Therapeutics to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference
GRAND CAYMAN, CAYMAN ISLANDS, Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi)...
Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference
MALVERN, Pa., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing,...
Celularity’s Strategic Partner Announces Groundbreaking for State-of-the-Art Stem Cell & Regenerative Medicine Center in Asia Pacific
Celularity is collaborating with its strategic partner, Genting Berhad, to bring Celularity placenta-derived allogeneic stem cell therapeutics to the Asia...
Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System
ST. LOUIS, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for...